SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Panel To Review Studies Of Cyberonics Device

December 27, 2006 | 
1 min read
WASHINGTON (Reuters) - A U.S. Food and Drug Administration advisory panel next month will review data on the use of Cyberonics Inc.'s VNS therapy device for depression since its approval, the agency said on Tuesday.
Regulatory
MORE ON THIS TOPIC
FDA
Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview
April 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Rug pull crypto, scam coin, trading problem, investment risk in unstable and uncertainty stock market concepts. Unknown people pull carpet and make businesspeople who standing on money falling down.
FDA
FDA’s User Fee Negotiation Teams Gutted by Layoffs: Reuters
April 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Food and Drug Administration building
FDA
FDA Moves to Restrict Industry Influence on Advisory Committees
April 18, 2025
 · 
2 min read
 · 
Tristan Manalac
ASD autism neurodevelopmental spectrum disorder, deficits in social communication and interaction, brain with impairment, hypersensitivity and abnormalities
Editorial
Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham
April 17, 2025
 · 
3 min read
 · 
Dan Samorodnitsky